Interestingly, under adherent culture conditions, PRT1419 had no effects on cell growth in both PBRM1 mutant and WT ccRCC, consistent with previous reports evaluating other MCL1 inhibitors (Supplementary Figure S1A). The gene discussed is PBRM1; the disease is nonpapillary renal cell carcinoma.